Mutagen sensitivity exhibits a dose-response relationship in case- control studies

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 7, 1996, Pages 577-578

  Wu, Xifeng ^a,b   Hsu, T C ^a   Spitz, Margaret R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN;

ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME DAMAGE; DOSE RESPONSE; HUMAN; HUMAN CELL; LUNG CANCER; MUTAGENESIS; PRIORITY JOURNAL;

4-NITROQUINOLINE-1-OXIDE; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; CASE-CONTROL STUDIES; CELL CULTURE TECHNIQUES; CHROMATIDS; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; LYMPHOCYTES; MELANOMA; MUTAGENS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 0030017756     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Hsu, T. C. Genetic instability in the human population: a working hypothesis. Hereditas, 98: 1-11, 1983.
2. Hsu, T. C., Johnston, D. A., Cherry, L. M., Ramkisson, D., Schantz, S. P., Jessup, J. M., Winn, R. J., Shirley, L., and Furlong, C. Sensitivity to genotoxical effects of bleomycin in humans: possible relationship to environmental carcino-genesis. Int. J. Cancer, 43: 403-409, 1989.
3. Hsu, T. C., Feun, L., Trizna, Z., Savaraji, N., Shirley, L. R., Furlong, C. L., Schantz, S. P., Weber, R. S., Shen, T. J., and Kucuk, O. Differential sensitivity among three human subpopulations in response to 4-nitroquinoline-1-oxide and to bleomycin. Int. J. Oncol., 3: 827-830, 1993.
4. Lee, J. J., Trizna, Z., Hsu, T. C., Spitz, M. R., and Hong, W. K. A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay. Cancer Epidemiol., Biomarkers & Prev., 5: 191-197, 1996.
5. Spitz, M. R., Hsu, T. C, Wu, X. F., Fueger, J. J., Amos, C. I., and Roth, J. A. Mutagen sensitivity as a biologic marker of lung cancer risk in African-Americans. Cancer Epidemiol., Biomarkers & Prev., 4: 99-103, 1995.
6. Wu, X., Delclos, G. L., Annegers, J. F., Bondy, M. L., Honn, S. E., Henry, B., Hsu, T. C., and Spitz, M. R. A case-control study of wood dust exposure, mutagen sensitivity, and lung cancer risk. Cancer Epidemiol., Biomarkers & Prev., 4: 583-588, 1995.
7. Woolf, B. On estimating the relation between blood group and disease. Ann. Hum. Genet., 19: 251-253. 1955.
8. Stata Corp, 1995. Statistical Software: Release 4.0 College Station, TX: Stata Corporation.